<DOC>
	<DOCNO>NCT02185170</DOCNO>
	<brief_summary>The aim study divide 4 different step : - first step two different purpose : assess impact storage medium fresh prostatic chip fluorescence signal adjust entire chain ( immunolabelling , counter-stain imaging ) , - second step adaptation immunolabelling protocol histopathology slide , use fresh prostatic tissue , - third step validate use : 1. medical device create FEMTO-ST institute use detection fluorescence signal fresh tissue , 2. Light-CT scanner use tissue structural observation . - four step check preservation morphological structure tissue effect laser excitation medical device .</brief_summary>
	<brief_title>DEPORRA-CoProst : Assessment New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections</brief_title>
	<detailed_description />
	<criteria>Male patient 18 year old . Patient schedule transurethral resection prostate : 1. prostate specific antigen ( PSA ) blood level â‰¤ 4 ng/ml age &gt; 80 year old 2. suspected prostate cancer digital rectal examination ( DRE ) PSA blood level &gt; 50 ng/ml exist prostate cancer Patient affiliate social security beneficiary regime . Protected patient refer Articles L11216 L11218 Code Public Health</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
	<keyword>Medical Device</keyword>
	<keyword>Fluorescence</keyword>
</DOC>